Key player in ovarian cancer may have implications for PCOS

Researchers explore the involvement and altered expression of BBOX1-AS1 and microRNA-19b in polycystic ovary syndrome.

Bristol Myers gets regulatory clearance to close Mirati deal as FTC increases pressure on pharma M&A

Bristol Myers Squibb has the go-ahead from antitrust regulators to complete its $4.8 billion takeover of Mirati. Increased FTC scrutiny has put large pharma mergers

December 21, 2023

Opinion | How to Better Manage ‘No Show’ Appointments

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director

January 14, 2025

Discovery of promising protein candidate opens new avenues for treating metabolic disorders

A University of Saskatchewan (USask) research team’s discovery of the additional health benefits of an appetite-suppressing protein has doubled the potential for scientists to find

May 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.